Adil Syed M, Han Jing L, Parente Beth A, Hickey Patrick, Lad Shivanand P
Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina, USA.
Department of Surgery, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA.
Stereotact Funct Neurosurg. 2019;97(1):31-36. doi: 10.1159/000494737. Epub 2019 Apr 4.
Spinal cord stimulation (SCS) is a well-established therapy for chronic pain syndromes, with growing applicability to other conditions. Restless legs syndrome (RLS) is a widespread, chronic movement disorder managed primarily and incompletely by medication, and its etiology can be classified as idiopathic or secondary.
Three patients underwent SCS implantation for chronic back and/or leg pain with concomitant targeting of RLS: (1) a 34-year-old man with sporadic RLS symptoms that strongly intensified after military-related spinal fractures, (2) a 54-year-old man with RLS likely secondary to meralgia paresthetica, and (3) a 42-year-old man with low back and right lower extremity pain after a military motor vehicle accident.
Continuing through 40-month, 2-month, and 28-month follow-ups, respectively, the patients experienced exemplary relief of their RLS symptoms. Notably in the case of patient 1, this benefit appears separate from his pain relief, as during the 5-month period directly after surgery but before adjusted targeting, he only experienced pain alleviation.
To our knowledge, this is the first reported case of using SCS as a potentially long-lasting, safe, and highly effective therapy for RLS of mixed etiology. Additionally, 2 patients with RLS possibly secondary to chronic pain also benefited from the therapy. This success may be due to increased inhibition from hypothalamic cells controlling dopaminergic input to the spine.
脊髓刺激(SCS)是一种针对慢性疼痛综合征的成熟疗法,其在其他病症中的适用性也在不断增加。不安腿综合征(RLS)是一种广泛存在的慢性运动障碍,主要通过药物治疗,但效果不完全理想,其病因可分为特发性或继发性。
三名患者接受了SCS植入手术,用于治疗慢性背部和/或腿部疼痛,并同时针对RLS进行治疗:(1)一名34岁男性,患有散发性RLS症状,在与军事相关的脊柱骨折后症状明显加重;(2)一名54岁男性,RLS可能继发于感觉异常性股痛;(3)一名42岁男性,在军事机动车事故后出现下背部和右下肢疼痛。
分别经过40个月、2个月和28个月的随访,患者的RLS症状得到了显著缓解。值得注意的是,在患者1的案例中,这种益处似乎与疼痛缓解无关,因为在手术后直接进行但未调整靶点的5个月期间,他只经历了疼痛减轻。
据我们所知,这是首例报道使用SCS作为一种可能持久、安全且高效的疗法来治疗混合病因RLS的案例。此外,2名可能继发于慢性疼痛的RLS患者也从该疗法中受益。这一成功可能是由于控制脊髓多巴胺能输入的下丘脑细胞的抑制作用增强。